METHOD FOR DIFFERENTIATED CONTROL OF BASIC ANTI-INFLAMMATORY TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN AND ADOLESCENTS Russian patent published in 2014 - IPC A61B5/87 A61B5/91 A61B5/145 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to pulmonology and allergology, and can be used for treating bronchial asthma (BA) in children and adolescents. That is ensured by determining clinical, functional, cytological, biochemical, immunological allergic inflammation activity markers (AIAMs). These markers are evaluated according to the developed scales. The total score is calculated according to each scale separately. Allergic inflammation activity indices (AIAIs) are calculated by the certain formulas taking into account the calculated total scores according to each scale. An integrative AIAI is calculated. An allergic inflammation activity degree (AIAD) is determined depending on the integrative AIAI. If the AIAD is 0, therapy required for the stage I basic anti-inflammatory therapy of BA is conducted. The 1^st AIAD requires therapy corresponding to the stage II basic therapy. The 2^nd AIAD requires therapy corresponding to the 3^rd stage therapy; the 3^rd AIAD provides therapy corresponding to the 4^th stage basic anti-inflammatory therapy of BA.

EFFECT: method provides a differentiated approach to selecting a volume of basic therapy of the given disease by accurate diagnosing of a degree of activity of the allergic inflammatory process in the airway walls that in its turn provides reducing a rate of attacks and length of aggravations in prolonging BA remission.

2 ex, 10 tbl